Viral Infection clinical trials at University of California Health

• Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)

  open to eligible people ages 1 month to 30 years

  BK cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Cytokine Capture System will be safe and effective in decreasing specific viral load in children, adolescents and young adults (CAYA) with refractory BK infection post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) or with primary immunodeficiencies (PID).

  at UCSF

Last updated: February 19, 2021